Immune biomarkers in the spectrum of childhood noncommunicable diseases

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 5, 2016, Pages 1302-1316

  Skevaki, Chrysanthi ^a,b   Van Den Berg, Jolice ^a,c   Jones, Nicholas ^a,d   Garssen, Johan ^a,e   Vuillermin, Peter ^a,f   Levin, Michael ^a,g   Landay, Alan ^a,c   Renz, Harald ^a,b   Calder, Philip C ^a,h   Thornton, Catherine A ^a,d  

^a International Inflammation (In FLAME) Network of the World Universities Network   (United States)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c RUSH UNIVERSITY   (United States)

^d SWANSEA UNIVERSITY   (United Kingdom)

^e UTRECHT UNIVERSITY   (Netherlands)

^f DEAKIN UNIVERSITY   (Australia)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Biomarkers; blood; breath; children; inflammation; mass spectrometry; microRNA; noncommunicable diseases; urine

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNITY; CHILDHOOD DISEASE; DATA ANALYSIS; DISEASE SEVERITY; FOOD ALLERGY; HUMAN; INFLAMMATORY BOWEL DISEASE; NEOPLASM; NON COMMUNICABLE DISEASE; PRIORITY JOURNAL; REVIEW; AUTOIMMUNE DISEASE; CHILD; CHILD HEALTH; HYPERSENSITIVITY; IMMUNOLOGY;

AUTOIMMUNE DISEASES; BIOMARKERS; CHILD; CHILD HEALTH; HUMANS; HYPERSENSITIVITY; INFLAMMATORY BOWEL DISEASES; NEOPLASMS;

EID: 84964804105     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.03.012     Document Type: Review

References (165)

1. S. Prescott, and A. Nowak-Wegrzyn Strategies to prevent or reduce allergic disease Ann Nutr Metab 59 suppl 1 2011 28 42
2. L. Rosenbaum, and D. Lamas Facing a "slow-motion disaster" - the UN meeting on noncommunicable diseases N Engl J Med 365 2011 2345 2348
3. R. Beaglehole, R. Bonita, R. Horton, C. Adams, G. Alleyne, P. Asaria, and et al. Priority actions for the non-communicable disease crisis Lancet 377 2011 1438 1447
4. S.L. Prescott Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases J Allergy Clin Immunol 131 2013 23 30
5. R. Geneau, D. Stuckler, S. Stachenko, M. McKee, S. Ebrahim, S. Basu, and et al. Raising the priority of preventing chronic diseases: A political process Lancet 376 2010 1689 1698
6. S. Yusuf, S. Hawken, S. Ounpuu, T. Dans, A. Avezum, F. Lanas, and et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
7. A. Alwan, D.R. Maclean, L.M. Riley, E.T. d'Espaignet, C.D. Mathers, G.A. Stevens, and et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries Lancet 376 2010 1861 1868
8. S.L. Prescott, and V. Clifton Asthma and pregnancy: emerging evidence of epigenetic interactions in utero Curr Opin Allergy Clin Immunol 9 2009 417 426
9. R. Medzhitov Origin and physiological roles of inflammation Nature 454 2008 428 435
10. M.F. Gregor, and G.S. Hotamisligil Inflammatory mechanisms in obesity Annu Rev Immunol 29 2011 415 445
11. C.E. West, H. Renz, M.C. Jenmalm, A.L. Kozyrskyj, K.J. Allen, P. Vuillermin, and et al. The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies J Allergy Clin Immunol 135 2015 3 14
12. A.E. Wold The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? Allergy 53 1998 20 25
13. M.C. de Goffau, K. Luopajarvi, M. Knip, J. Ilonen, T. Ruohtula, T. Harkonen, and et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without Diabetes 62 2013 1238 1244
14. J. Penders, K. Gerhold, E.E. Stobberingh, C. Thijs, K. Zimmermann, S. Lau, and et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood J Allergy Clin Immunol 132 2013 601 607.e8
15. D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, and N.R. Pace Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc Natl Acad Sci U S A 104 2007 13780 13785
16. K.M. Godfrey, P.D. Gluckman, and M.A. Hanson Developmental origins of metabolic disease: life course and intergenerational perspectives Trends Endocrinol Metab 21 2010 199 205
17. K. Strimbu, and J.A. Tavel What are biomarkers? Curr Opin HIV AIDS 5 2010 463 466
18. P.C. Calder Biomarkers of immunity and inflammation for use in nutrition interventions: International Life Sciences Institute European Branch work on selection criteria and interpretation Endocr Metab Immune Disord Drug Targets 14 2014 236 244
19. N. Rifai, and R.E. Gerszten Biomarker discovery and validation Clin Chem 52 2006 1635 1637
20. N.L. Anderson, and N.G. Anderson The human plasma proteome: history, character, and diagnostic prospects Mol Cell Proteomics 1 2002 845 867
21. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
22. Y. He, J. Lin, D. Kong, M. Huang, C. Xu, T.K. Kim, and et al. Current state of circulating microRNAs as cancer biomarkers Clin Chem 61 2015 1138 1155
23. Y.R. Li, J. Li, S.D. Zhao, J.P. Bradfield, F.D. Mentch, S.M. Maggadottir, and et al. Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases Nat Med 21 2015 1018 1027
24. C.A. Akdis, and I. Agache Global atlas of allergy 2014 European Academy of Allergy and Clinical Immunology Available at: http://www.eaaci.org/globalatlas/GlobalAtlasAllergy.pdf. Accessed April 6, 2016
25. J.A. Odhiambo, H.C. Williams, T.O. Clayton, C.F. Robertson, and M.I. Asher Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three J Allergy Clin Immunol 124 2009 1251 1258.e23
26. S.L. Prescott, R. Pawankar, K.J. Allen, D.E. Campbell, J.K. Sinn, A. Fiocchi, and et al. A global survey of changing patterns of food allergy burden in children World Allergy Org J 6 2013 1 12
27. S.A. Alduraywish, C.J. Lodge, B. Campbell, K.J. Allen, B. Erbas, A.J. Lowe, and et al. The march from early life food sensitization to allergic disease: A systematic review and meta-analyses of birth cohort studies Allergy 71 2016 77 89
28. S.F. Thomsen Epidemiology and natural history of atopic diseases Eur Clin Respir J 2 2015 10.3402/ecrj.v2.24642
29. G. Halmerbauer, T. Frischer, and D.Y. Koller Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood Allergy 52 1997 765 769
30. T.F. Leung, K.W. Ching, A.P. Kong, G.W. Wong, J.C. Chan, and K.L. Hon Circulating LL-37 is a biomarker for eczema severity in children J Eur Acad Dermatol Venereol 26 2012 518 522
31. M.H. Ezzat, Z.E. Hasan, and K.Y. Shaheen Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring J Eur Acad Dermatol Venereol 25 2011 334 339
32. K.L. Hon, T.F. Leung, K.C. Ma, C.K. Wong, H. Wan, and C.W. Lam Serum concentration of IL-18 correlates with disease extent in young children with atopic dermatitis Pediatr Dermatol 21 2004 619 622
33. M.H. Ezzat, M.A. Sallam, and K.Y. Shaheen Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: A specific marker for severity Int J Dermatol 48 2009 822 829
34. T. Fujisawa, M. Nagao, Y. Hiraguchi, H. Katsumata, H. Nishimori, K. Iguchi, and et al. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis Pediatr Allergy Immunol 20 2009 633 641
35. K.L. Hon, T.F. Leung, K.C. Ma, A.M. Li, Y. Wong, and T.F. Fok Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children Clin Exp Dermatol 29 2004 293 296
36. Y. Kataoka Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis J Dermatol 41 2014 221 229
37. Y. Lv, R. Qi, J. Xu, Z. Di, H. Zheng, W. Huo, and et al. Profiling of serum and urinary microRNAs in children with atopic dermatitis PLoS One 9 2014 e115448
38. T.X. Lu, J.D. Sherrill, T. Wen, A.J. Plassard, J.A. Besse, J.P. Abonia, and et al. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers J Allergy Clin Immunol 129 2012 1064 1075.e9
39. A. Rebane microRNA and Allergy Adv Exp Med Biol 888 2015 331 352
40. Y. Huang, G. Chen, X. Liu, Y. Shao, P. Gao, C. Xin, and et al. Serum metabolomics study and eicosanoid analysis of childhood atopic dermatitis based on liquid chromatography-mass spectrometry J Proteome Res 13 2014 5715 5723
41. Y.S. Kim, S.Y. Hwang, S. Oh, H. Sohn, H.Y. Kang, J.H. Lee, and et al. Identification of target proteins of N-acetylglucosaminyl-transferase V and fucosyltransferase 8 in human gastric tissues by glycomic approach Proteomics 4 2004 3353 3358
42. W.K. Kim, H.R. Hwang, H. Kim do, P.Y. Lee, Y.J. In, H.Y. Ryu, and et al. Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers Exp Mol Med 40 2008 677 685
43. S. Mayumi, N. Kamemura, M. Nagao, M. Irahara, S. Kagami, T. Fujisawa, and et al. Differential response in allergen-specific IgE, IgGs and IgA levels for predicting outcome of oral immunotherapy Pediatr Allergy Immunol 2016 Epub ahead of print
44. B.P. Vickery, L. Pons, M. Kulis, P. Steele, S.M. Jones, and A.W. Burks Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance Ann Allergy Asthma Immunol 105 2010 444 450
45. L. Orivuori, K. Mustonen, M.C. de Goffau, S. Hakala, M. Paasela, C. Roduit, and et al. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6 Clin Exp Allergy 45 2015 928 939
46. S.Y. Oh, J. Chung, M.K. Kim, S.O. Kwon, and B.H. Cho Antioxidant nutrient intakes and corresponding biomarkers associated with the risk of atopic dermatitis in young children Eur J Clin Nutr 64 2010 245 252
47. G.E. Schoeters, E. Den Hond, G. Koppen, R. Smolders, K. Bloemen, P. De Boever, and et al. Biomonitoring and biomarkers to unravel the risks from prenatal environmental exposures for later health outcomes Am J Clin Nutr 94 2011 1964S 1969S
48. K.W. Su, P.C. Chen, and I.J. Wang Cord blood soluble Fas ligand and pediatric atopic dermatitis Allergy Asthma Proc 32 2011 366 371
49. H. Miyahara, N. Okazaki, T. Nagakura, S. Korematsu, and T. Izumi Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy Clin Exp Allergy 41 2011 186 191
50. N.V. Folsgaard, B.L. Chawes, K. Bonnelykke, M.C. Jenmalm, and H. Bisgaard Cord blood Th2-related chemokine CCL22 levels associate with elevated total-IgE during preschool age Clin Exp Allergy 42 2012 1596 1603
51. D.M. Bullens, S. Seys, A. Kasran, E. Dilissen, L.J. Dupont, and J.L. Ceuppens Low cord blood Foxp3/CD3gamma mRNA ratios: A marker of increased risk for allergy development Clin Exp Allergy 45 2015 232 237
52. D. Hinz, M. Bauer, S. Roder, S. Olek, J. Huehn, U. Sack, and et al. Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year Allergy 67 2012 380 389
53. M. Smith, M.R. Tourigny, P. Noakes, C.A. Thornton, M.K. Tulic, and S.L. Prescott Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+)CD127(lo/-) regulatory T cell function J Allergy Clin Immunol 121 2008 1460 1466 e1-7
54. D. Venkataraman, N. Soto-Ramirez, R.J. Kurukulaaratchy, J.W. Holloway, W. Karmaus, S.L. Ewart, and et al. Filaggrin loss-of-function mutations are associated with food allergy in childhood and adolescence J Allergy Clin Immunol 134 2014 876 882.e4
55. T. Holm, D. Rutishauser, Y. Kai-Larsen, Y. Lyutvinskiy, F. Stenius, R.A. Zubarev, and et al. Protein biomarkers in vernix with potential to predict the development of atopic eczema in early childhood Allergy 69 2014 104 112
56. X. Luo, H. Hong, J. Tang, X. Wu, Z. Lin, R. Ma, and et al. Increased expression of miR-146a in children with allergic rhinitis after allergen-specific immunotherapy Allergy Asthma Immunol Res 8 2016 132 140
57. H. Park, X. Huang, C. Lu, M.S. Cairo, and X. Zhou MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins J Biol Chem 290 2015 2831 2841
58. M.I. Asher, S. Montefort, B. Bjorksten, C.K. Lai, D.P. Strachan, S.K. Weiland, and et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys Lancet 368 2006 733 743
59. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, J.R. Arron, and et al. Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
60. J.V. Fahy Type 2 inflammation in asthma - present in most, absent in many Nat Rev Immunol 15 2015 57 65
61. P.G. Woodruff, B. Modrek, D.F. Choy, G. Jia, A.R. Abbas, A. Ellwanger, and et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma Am J Respir Crit Care Med 180 2009 388 395
62. D.F. Choy, K.M. Hart, L.A. Borthwick, A. Shikotra, D.R. Nagarkar, S. Siddiqui, and et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma Sci Transl Med 7 2015 301ra129
63. E.H. Bel, S.E. Wenzel, P.J. Thompson, C.M. Prazma, O.N. Keene, S.W. Yancey, and et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma N Engl J Med 371 2014 1189 1197
64. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, P. Bradding, and et al. Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial Lancet 360 2002 1715 1721
65. L. Jayaram, M.M. Pizzichini, R.J. Cook, L.P. Boulet, C. Lemiere, E. Pizzichini, and et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Eur Respir J 27 2006 483 494
66. I.D. Pavord, S. Korn, P. Howarth, E.R. Bleecker, R. Buhl, O.N. Keene, and et al. Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial Lancet 380 2012 651 659
67. F.H. Guo, K. Uetani, S.J. Haque, B.R. Williams, R.A. Dweik, F.B. Thunnissen, and et al. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators J Clin Invest 100 1997 829 838
68. N.A. Hanania, S. Wenzel, K. Rosen, H.J. Hsieh, S. Mosesova, D.F. Choy, and et al. Exploring the effects of omalizumab in allergic asthma: An analysis of biomarkers in the EXTRA study Am J Respir Crit Care Med 187 2013 804 811
69. B.D. Modena, J.R. Tedrow, J. Milosevic, E.R. Bleecker, D.A. Meyers, W. Wu, and et al. Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways Am J Respir Crit Care Med 190 2014 1363 1372
70. A.D. Smith, J.O. Cowan, S. Filsell, C. McLachlan, G. Monti-Sheehan, P. Jackson, and et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests Am J Respir Crit Care Med 169 2004 473 478
71. S. Wenzel, L. Ford, D. Pearlman, S. Spector, L. Sher, F. Skobieranda, and et al. Dupilumab in persistent asthma with elevated eosinophil levels N Engl J Med 368 2013 2455 2466
72. S. Gogate, and R. Katial Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4 Curr Opin Allergy Clin Immunol 8 2008 154 157
73. G. Takayama, K. Arima, T. Kanaji, S. Toda, H. Tanaka, S. Shoji, and et al. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals J Allergy Clin Immunol 118 2006 98 104
74. J.M. Lopez-Guisa, C. Powers, D. File, E. Cochrane, N. Jimenez, and J.S. Debley Airway epithelial cells from asthmatic children differentially express proremodeling factors J Allergy Clin Immunol 129 2012 990 997.e6
75. S.J. Conway, K. Izuhara, Y. Kudo, J. Litvin, R. Markwald, G. Ouyang, and et al. The role of periostin in tissue remodeling across health and disease Cell Mol Life Sci 71 2014 1279 1288
76. J.R. Konradsen, E. Skantz, B. Nordlund, M. Lidegran, A. James, J. Ono, and et al. Predicting asthma morbidity in children using proposed markers of Th2-type inflammation Pediatr Allergy Immunol 26 2015 772 779
77. J.S. Song, J.S. You, S.I. Jeong, S. Yang, I.T. Hwang, Y.G. Im, and et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma Allergy 70 2015 674 681
78. Y. Kanemitsu, H. Matsumoto, K. Izuhara, Y. Tohda, H. Kita, T. Horiguchi, and et al. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids J Allergy Clin Immunol 132 2013 305 312e3
79. D.V. Sawant, W. Yao, Z. Wright, C. Sawyers, R.S. Tepper, S.K. Gupta, and et al. Serum MicroRNA-21 as a biomarker for allergic inflammatory disease in children Microrna 4 2015 36 40
80. L. Midyat, F. Gulen, E. Karaca, F. Ozkinay, R. Tanac, E. Demir, and et al. MicroRNA expression profiling in children with different asthma phenotypes Pediatr Pulmonol 2015 Epub ahead of print
81. J.H. Shorter, D.D. Nelson, J.B. McManus, M.S. Zahniser, S.R. Sama, and D.K. Milton Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy J Breath Res 5 2011 037108
82. D. Smith, P. Spanel, J. Herbig, and J. Beauchamp Mass spectrometry for real-time quantitative breath analysis J Breath Res 8 2014 027101
83. M. Halonen, I.C. Lohman, D.A. Stern, W.L. Ellis, J. Rothers, and A.L. Wright Perinatal tumor necrosis factor-alpha production, influenced by maternal pregnancy weight gain, predicts childhood asthma Am J Respir Crit Care Med 188 2013 35 41
84. E.M. Klaassen, K.D. van de Kant, Q. Jobsis, O.C. van Schayck, A. Smolinska, J.W. Dallinga, and et al. Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age Am J Respir Crit Care Med 191 2015 201 207
85. K.D. van de Kant, M.A. Jansen, E.M. Klaassen, C.P. van der Grinten, G.T. Rijkers, J.W. Muris, and et al. Elevated inflammatory markers at preschool age precede persistent wheezing at school age Pediatr Allergy Immunol 23 2012 259 264
86. Y.L. Zhang, B. Luan, X.F. Wang, J.Y. Qiao, L. Song, R.R. Lei, and et al. Peripheral blood MDSCs, IL-10 and IL-12 in children with asthma and their importance in asthma development PLoS One 8 2013 e63775
87. L. Yu, D.T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes Proc Natl Acad Sci U S A 97 2000 1701 1706
88. M.R. Batstra, A. van Driel, J.S. Petersen, C.A. van Donselaar, M.J. van Tol, G.J. Bruining, and et al. Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values Clin Chem 45 1999 2269 2272
89. K. Decochez, B. Keymeulen, G. Somers, H. Dorchy, I.H. De Leeuw, C. Mathieu, and et al. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry Diabetes Care 23 2000 1072 1078
90. S. ilia, M.R. Casini, V.M. Cambuli, A. Ibba, P. Civolani, P. Zavattari, and et al. Prevalence of Type 1 diabetes autoantibodies (GAD and IA2) in Sardinian children and adolescents with autoimmune thyroiditis Diabet Med 28 2011 896 899
91. V. Lampasona, A. Petrone, C. Tiberti, M. Capizzi, M. Spoletini, S. di Pietro, and et al. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4 Diabetes Care 33 2010 104 108
92. E. Grodzinsky, A. Ivarsson, P. Juto, P. Olcen, K. Falth-Magnusson, L.A. Persson, and et al. New automated immunoassay measuring immunoglobulin A antigliadin antibodies for prediction of celiac disease in childhood Clin Diagn Lab Immunol 8 2001 564 570
93. T.T. Salmi, P. Collin, I.R. Korponay-Szabo, K. Laurila, J. Partanen, H. Huhtala, and et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits Gut 55 2006 1746 1753
94. I. Dahlbom, M. Olsson, N.K. Forooz, A.G. Sjoholm, L. Truedsson, T. Hansson, and G. Immunoglobulin (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients Clin Diagn Lab Immunol 12 2005 254 258
95. M. Kabelitz, K.P. Liesenkotter, B. Stach, H. Willgerodt, W. Stablein, W. Singendonk, and et al. The prevalence of anti-thyroid peroxidase antibodies and autoimmune thyroiditis in children and adolescents in an iodine replete area Eur J Endocrinol 148 2003 301 307
96. K.S. Torok, and T. Arkachaisri Autoimmune thyroiditis in antinuclear antibody positive children without rheumatologic disease Pediatr Rheumatol Online J 8 2010 15
97. J.L. McGhee, L.M. Kickingbird, and J.N. Jarvis Clinical utility of antinuclear antibody tests in children BMC Pediatr 4 2004 13
98. L.L. Chiang, Y.T. Lin, H.Y. Chan, and B.L. Chiang Differential manifestations of prepubescent, pubescent and postpubescent pediatric patients with systemic lupus erythematosus: A retrospective study of 96 Chinese children and adolescents Pediatr Rheumatol Online J 10 2012 12
99. E. Cozzani, M. Drosera, G. Gasparini, and A. Parodi Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects Autoimmune Dis 2014 2014 321359
100. B. Hugle, C. Hinze, E. Lainka, N. Fischer, and J.P. Haas Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course Pediatr Rheumatol Online J 12 2014 28
101. R. Gupta, M.M. Thabah, B. Vaidya, S. Gupta, R. Lodha, and S.K. Kabra Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis Indian J Pediatr 77 2010 41 44
102. B. Wittemann, G. Neuer, H. Michels, H. Truckenbrodt, and F.A. Bautz Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis Arthritis Rheumatol 33 1990 1378 1383
103. H.H. Yu, H.M. Chang, C.J. Chiu, Y.H. Yang, J.H. Lee, L.C. Wang, and et al. Detection of anti-p155/140, anti-p140, and antiendothelial cells autoantibodies in patients with juvenile dermatomyositis J Microbiol Immunol Infect 49 2016 264 270
104. Y. Muro, A. Ishikawa, K. Sugiura, and M. Akiyama Clinical features of anti-TIF1-alpha antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-gamma or anti-Mi-2 autoantibodies Rheumatology (Oxford) 51 2012 1508 1513
105. S.L. Tansley, N.J. McHugh, and L.R. Wedderburn Adult and juvenile dermatomyositis: Are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms? Arthritis Res Ther 15 2013 211
106. Y. Hacohen, M. Absoud, K. Deiva, C. Hemingway, P. Nytrova, M. Woodhall, and et al. Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children Neurol Neuroimmunol Neuroinflamm 2 2015 e81
107. B.I. Frohnert, and M.J. Rewers Metabolomics in childhood diabetes Pediatr Diabetes 17 2016 3 14
108. TEDDY Study Group The Environmental Determinants of Diabetes in the Young (TEDDY) study Ann N Y Acad Sci 1150 2008 1 13
109. H.S. Lee, B.R. Burkhardt, W. McLeod, S. Smith, C. Eberhard, K. Lynch, and et al. Biomarker discovery study design for type 1 diabetes in the Environmental Determinants of Diabetes in the Young (TEDDY) study Diabetes Metab Res Rev 30 2014 424 434
110. A.V. Churov, E.K. Oleinik, and M. Knip MicroRNAs in rheumatoid arthritis: Altered expression and diagnostic potential Autoimmun Rev 14 2015 1029 1037
111. R. Madsen, S. Rantapaa-Dahlqvist, T. Lundstedt, T. Moritz, and J. Trygg Metabolic responses to change in disease activity during tumor necrosis factor inhibition in patients with rheumatoid arthritis J Proteome Res 11 2012 3796 3804
112. H.A. van Wietmarschen, W. Dai, A.J. van der Kooij, T.H. Reijmers, Y. Schroen, M. Wang, and et al. Characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements PLoS One 7 2012 e44331
113. Q. Zhou, S. Haupt, J.T. Kreuzer, A. Hammitzsch, F. Proft, C. Neumann, and et al. Decreased expression of miR-146a and miR155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritic Ann Rheum Dis 74 2015 1265 1274
114. S.W. Kim, K. Ramasamy, H. Bouamar, A.P. Lin, D. Jiang, and R.C. Aguiar MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) Proc Natl Acad Sci U S A 109 2012 7865 7870
115. K. Murata, M. Furu, H. Yoshitomi, M. Ishikawa, H. Shibuya, M. Hashimoto, and et al. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis PLoS One 8 2013 e69118
116. D. Van Schaardenburg, M Murphy, Y. Gui, S. Turk, W.P. Maksymowych, and A. Marotta Change in 14-3-3' expression in early RA patients treated with dmards corresponds with change in DAS28 and good EULAR responses Arthritis Rheumatol 2014 S837
117. W.P. Maksymowych, and A. Marotta 14-3-3eta: A novel biomarker platform for rheumatoid arthritis Clin Exp Rheumatol 32 2014 S-35 S-39
118. M. Jasek, K. Malyavantham, L. Suresh, J.J. Ambrus, and D. Pardo Sjo (TM) an advanced diagnostic panel for detection of Sjogren's syndrome autoantibodies, arthritis Rheumatol 2014 S1110
119. L. Shen, L. Suresh, M. Lindemann, J. Xuan, P. Kowal, K. Malyavantham, and et al. Novel autoantibodies in Sjogren's syndrome Clin Immunol 145 2012 251 255
120. P. Vermeersch, and X. Bossuyt Prevalence and clinical significance of rare antinuclear antibody patterns Autoimmun Rev 12 2013 998 1003
121. V. Chandran, A. Thavaneswaran, and D.D. Gladman Neutrophil-lymphocyte ratio as a marker of disease activity in psoriatic arthritis Arthritis Rheumatol 2014 S704
122. J.B. Draibe, R.J. Pepper, P.A. Merkel, A.D. Salama Investigators R-I Serum calprotectin and disease relapse in ANCA-associated vasculitis Arthritis Rheumatol 2014 S818
123. J.H. Stone, P.A. Merkel, R. Spiera, P. Seo, C.A. Langford, G.S. Hoffman, and et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med 363 2010 221 232
124. A. Perl mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging Ann N Y Acad Sci 1346 2015 33 44
125. P. Malmborg, L. Grahnquist, J. Lindholm, S. Montgomery, and H. Hildebrand Increasing incidence of paediatric inflammatory bowel disease in northern Stockholm County, 2002-2007 J Pediatr Gastroenterol Nutr 57 2013 29 34
126. U. Kopylov, G. Rosenfeld, B. Bressler, and E. Seidman Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease Inflamm Bowel Dis 20 2014 742 756
127. J.D. Lewis The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease Gastroenterology 140 2011 1817 1826.e2
128. A. Zholudev, D. Zurakowski, W. Young, A. Leichtner, and A. Bousvaros Serologic testing with anti-neutrophil cytoplasmic antibody (ANCA), anti-Saccharomyces cerevisiae antibody (ASCA), and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype Am J Gastroenterol 99 2004 2235 2241
129. U. Grzybowska-Chlebowczyk, H. Wos, A.L. Sieron, S. Wiecek, A. Augusciak-Duma, H. Koryciak-Komarska, and et al. Serologic investigations in children with inflammatory bowel disease and food allergy Mediators Inflamm 2009 2009 512695
130. H. Huang, P. Vangay, C.E. McKinlay, and D. Knights Multi-omics analysis of inflammatory bowel disease Immunol Lett 162 2014 62 68
131. A.E. M'Koma Diagnosis of inflammatory bowel disease: potential role of molecular biometrics World J Gastrointest Surg 6 2014 208 219
132. Y. Huang, D.A. Lemberg, A.S. Day, B. Dixon, S. Leach, Y. Bujanover, and et al. Markers of inflammation in the breath in paediatric inflammatory bowel disease J Pediatr Gastroenterol Nutr 59 2014 505 510
133. M. Hubenthal, G. Hemmrich-Stanisak, F. Degenhardt, S. Szymczak, Z. Du, A. Elsharawy, and et al. Sparse modeling reveals miRNA signatures for diagnostics of inflammatory bowel disease PLoS One 10 2015 e0140155
134. J.A. Thompson, and R.C. Webb Potential role of Toll-like receptors in programming of vascular dysfunction Clin Sci (Lond) 125 2013 19 25
135. V.M. Cambuli, M.C. Musiu, M. Incani, M. Paderi, R. Serpe, V. Marras, and et al. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children J Clin Endocrinol Metab 93 2008 3051 3057
136. J. Davignon, and P. Ganz Role of endothelial dysfunction in atherosclerosis Circulation 109 2004 III27 III32
137. F. Sabatier, L. Camoin-Jau, F. Anfosso, J. Sampol, and F. Dignat-George Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence J Cell Mol Med 13 2009 454 471
138. L. Bruyndonckx, V.Y. Hoymans, G. Frederix, A. De Guchtenaere, H. Franckx, D.K. Vissers, and et al. Endothelial progenitor cells and endothelial microparticles are independent predictors of endothelial function J Pediatr 165 2014 300 305
139. A. Khalyfa, L. Kheirandish-Gozal, R. Bhattacharjee, A.A. Khalyfa, and D. Gozal Circulating miRNAs as potential biomarkers of endothelial dysfunction in obese children Chest 149 2016 786 800
140. E. Carolan, A.E. Hogan, M. Corrigan, G. Gaotswe, J. O'Connell, N. Foley, and et al. The impact of childhood obesity on inflammation, innate immune cell frequency, and metabolic microRNA expression J Clin Endocrinol Metab 99 2014 E474 E478
141. N. Stoicea, A. Du, D.C. Lakis, C. Tipton, C.E. Arias-Morales, and S.D. Bergese The miRNA journey from theory to practice as a CNS biomarker Front Genet 7 2016 11
142. J.M. Goodson, A. Kantarci, M.L. Hartman, G.V. Denis, D. Stephens, H. Hasturk, and et al. Metabolic disease risk in children by salivary biomarker analysis PLoS One 9 2014 e98799
143. V.S. Farook, L. Reddivari, G. Chittoor, S. Puppala, R. Arya, S.P. Fowler, and et al. Metabolites as novel biomarkers for childhood obesity-related traits in Mexican-American children Pediatr Obes 10 2015 320 327
144. P.R. West, D.G. Amaral, P. Bais, A.M. Smith, L.A. Egnash, M.E. Ross, and et al. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children PLoS One 9 2014 e112445
145. P. Whiteley, R. Waring, L. Williams, L. Klovrza, F. Nolan, S. Smith, and et al. Spot urinary creatinine excretion in pervasive developmental disorders Pediatr Int 48 2006 292 297
146. D. Norata Giuseppe, G. Caligiuri, T. Chavakis, G. Matarese, G. Netea Mihai, A. Nicoletti, and et al. The cellular and molecular basis of translational immunometabolism Immunity 43 2015 421 434
147. Z. Kos, and D.J. Dabbs Biomarker assessment and molecular testing for prognostication in breast cancer Histopathology 68 2016 70 85
148. N.H. Tran, L.L. Cavalcante, S.J. Lubner, D.L. Mulkerin, N.K. LoConte, L. Clipson, and et al. Precision medicine in colorectal cancer: the molecular profile alters treatment strategies Ther Adv Med Oncol 7 2015 252 262
149. A. Fusi, L. Festino, G. Botti, G. Masucci, I. Melero, P. Lorigan, and et al. PD-L1 expression as a potential predictive biomarker Lancet Oncol 16 2015 1285 1287
150. R.S. Herbst, J.C. Soria, M. Kowanetz, G.D. Fine, O. Hamid, M.S. Gordon, and et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients Nature 515 2014 563 567
151. S.P. Patel, and R. Kurzrock PD-L1 expression as a predictive biomarker in cancer immunotherapy Mol Cancer Ther 14 2015 847 856
152. M. Ilie, V. Hofman, M. Dietel, J.C. Soria, and P. Hofman Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients Virchows Arch 2016 Epub ahead of print
153. S. Hirsch, L.V. Marshall, F. Carceller Lechon, A.D. Pearson, and L. Moreno Targeted approaches to childhood cancer: progress in drug discovery and development Expert Opin Drug Discov 10 2015 483 495
154. L. Shi, J. Zhang, P. Wu, K. Feng, J. Li, Z. Xie, and et al. Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia Proteome Sci 7 2009 7
155. M.D. Russell, A.M. Young, and S.K. Karri Biomarkers of pediatric brain tumors Front Pediatr 1 2013 7
156. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube, M. Gion, G.M. Clark, and et al. REporting recommendations for tumor MARKer prognostic studies (REMARK) Nat Clin Pract Oncol 2 2005 416 422
157. J.R. Whiteaker, C. Lin, J. Kennedy, L. Hou, M. Trute, I. Sokal, and et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma Nat Biotechnol 29 2011 625 634
158. G.V. Cohen Freue, A. Meredith, D. Smith, A. Bergman, M. Sasaki, K.K. Lam, and et al. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation PLoS Comput Biol 9 2013 e1002963
159. F.M. Goodsaid, F.W. Frueh, and W. Mattes The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the critical path Drug Discov Today Technol 4 2007 47 50
160. J.R. Whiteaker, H. Zhang, L. Zhao, P. Wang, K.S. Kelly-Spratt, R.G. Ivey, and et al. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer J Proteome Res 6 2007 3962 3975
161. H. Shin, and M.K. Markey A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples J Biomed Inform 39 2006 227 248
162. K.E. Diggins, P.B. Ferrell Jr., and J.M. Irish Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data Methods 82 2015 55 63
163. K. O'Neill, N. Aghaeepour, J. Spidlen, and R. Brinkman Flow cytometry bioinformatics PLoS Comput Biol 9 2013 e1003365
164. H.T. Maecker, J.P. McCoy, and R. Nussenblatt Standardizing immunophenotyping for the Human Immunology Project Nat Rev Immunol 12 2012 191 200
165. S.U. Meyer, M.W. Pfaffl, and S.E. Ulbrich Normalization strategies for microRNA profiling experiments: A 'normal' way to a hidden layer of complexity? Biotechnol Lett 32 2010 1777 1788